PPD Names New CEO

Raymond H. Hill has been named chief executive officer of PPD, Inc. and has been elected to the company’s board. Mr. Hill comes to PPD after eight years with IMS Health, Inc., a provider of data, market research and consulting services to clients in the pharmaceutical and health care industries. He most recently served as president of IMS Consulting Group. During his tenure at IMS, he oversaw a strategy of aggressive organic and acquisition-based growth. Annual revenue increased five-fold in seven years. He also served on the executive leadership team of IMS, helping to set the overall direction of the company.

“With more than 20 years of experience in the life sciences arena, Ray brings keen strategic acumen as a proven leader who has grown global client services businesses in the pharmaceutical industry,” said Fred Eshelman, executive chairman of PPD. “His consistent track record of business success and disciplined approach to operational and financial performance make him well suited for our CEO role.”

Prior to his tenure at IMS Health, Mr. Hill was senior vice president for Acumen Sciences. Mr. Hill held several roles in eight years at A.T. Kearney, including global head, pharmaceuticals and healthcare practice, in which he led the creation of the practice, hired the team of healthcare professionals and grew annual revenue to $45 million. In a six-year stint that culminated with him serving as senior associate in the energy, chemicals and pharmaceuticals practice of Booz Allen & Hamilton Inc., Mr. Hill gravitated to the healthcare side of the practice, which set him on his career path in the life sciences arena.